This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Abbvie Inc.. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Framingham, MA (US) (2013)
- Ashland, MA (US) (2014 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: Gagandeep K Somal: Innovator in Pharmaceutical Research
Introduction
Gagandeep K Somal is a prominent inventor based in Ashland, MA (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target immunological and oncological conditions. With a total of 4 patents to his name, Somal's work is recognized for its potential impact on medical treatments.
Latest Patents
Somal's latest patents include innovative compounds that serve as BTK inhibitors. The first patent focuses on primary carboxamides, providing compounds of Formula (I) along with pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers. These compounds are designed to treat various immunological and oncological conditions. Another significant patent involves heterocyclic nuclear hormone receptor modulators, which also presents a compound of Formula (I) with similar applications in treating immunological and oncological conditions.
Career Highlights
Gagandeep K Somal is currently associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie has allowed him to focus on groundbreaking research that aims to improve patient outcomes through innovative drug development.
Collaborations
Throughout his career, Somal has collaborated with notable colleagues, including Michael Z Hoemann and Michael M Friedman. These collaborations have contributed to the advancement of research in the pharmaceutical field.
Conclusion
Gagandeep K Somal's contributions to pharmaceutical research through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments in immunology and oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile